# Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers

> **NCT01838902** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 467 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** DHA-PPQ
- **DRUG:** PQ (0.75)
- **DRUG:** PQ (0.4)
- **DRUG:** PQ (0.2)

## Key facts

- **NCT ID:** NCT01838902
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-10
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2018-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838902, "Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01838902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*